Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


Pfizer Animal Health Strengthens Local Market

Pfizer Animal Health Strengthens Local Market

Pfizer Animal Health has been significantly strengthened by Pfizer Inc’s global acquisition of Pharmacia Corporation, completed on April 16th 2003. The New Zealand division of Pfizer Animal Health is pleased to announce this development, and looks forward to building on its offering to the local market.

Pfizer Animal Health Division Director, Craig Patterson says the acquisition is an exciting opportunity for the Animal Health business.

“Pharmacia's livestock and companion animal customers can look forward to benefiting from Pfizer’s commitment to technical support and ongoing local field force investment. Many of the changes that will take place in the coming months offer exciting new opportunities to the valued customers of both organisations. Internationally, Pfizer is the leader in animal health research and development and invests millions in maximising scientific and technological expertise. The acquisition means product innovation and investment will be strengthened internationally with the benefits ultimately flowing through to New Zealand.”

Changes to the Pharmacia/Pfizer Animal Health team include an expansion of the field force to include a new pastoral team whose role is to focus on meeting the needs of farmers, while supporting Pfizer’s vet-only Dectomax distribution strategy. This new team will be complementary to the existing companion animal, and vet ethical teams.

These changes will be phased in over the next 2 months, meaning for all Pfizer Animal Health and Pharmacia customers it is business as usual.

Says Craig; “The field force will soon be talking to veterinarians, and their key farmer contacts explaining the changes, providing additional information and working closely to ensure a smooth transition period.”

The acquisition means Pfizer Animal Health globally will divest itself of the Cue-Mate product due to the requirements of competition law regulators in Australia and New Zealand. In Cidr we have an excellent market leading product which provides Pfizer with the ability to develop and grow the reproductive market. Cue-Mate will still be available to veterinary practices pending completion of the divestment, and the divestment of Pfizer’s Cue-Mate business will not take place until an appropriate buyer is located. We would anticipate that this would take some months to complete.

Pfizer Animal Health in New Zealand is recognised as a leader in the livestock and companion animal pharmaceutical markets, with many innovative products meeting the needs of livestock and pets in the local market. Internationally, Pfizer treats every major animal species in over 140 countries.

Any queries from customers can be addressed to:

Pfizer Animal Health Products Customer Services: 0800 100 109 Pharmacia Animal Health Customer Services: 0800 735 730

© Scoop Media

Business Headlines | Sci-Tech Headlines


I Sing The Highway Electric: Charge Net NZ To Connect New Zealand

BMW is turning Middle Earth electric after today announcing a substantial contribution to the charging network Charge Net NZ. This landmark partnership will enable Kiwis to drive their electric vehicles (EVs) right across New Zealand through the installation of a fast charging highway stretching from Kaitaia to Invercargill. More>>


Watch This Space: Mahia Rocket Lab Launch Site Officially Opened

Economic Development Minster Steven Joyce today opened New Zealand’s first orbital launch site, Rocket Lab Launch Complex 1, on the Mahia Peninsula on the North Island’s east coast. More>>


Marketing Rocks!
Ig Nobel Award Winners Assess The Personality Of Rocks

A Massey University marketing lecturer has received the 2016 Ig Nobel Prize for economics for a research project that asked university students to describe the “brand personalities” of three rocks. More>>


Nurofen Promotion: Reckitt Benckiser To Plead Guilty To Misleading Ads

Reckitt Benckiser (New Zealand) intends to plead guilty to charges of misleading consumers over the way it promoted a range of Nurofen products, the Commerce Commission says. More>>


Half A Billion Accounts, Including Xtra: Yahoo Confirms Huge Data Breach

The account information may have included names, email addresses, telephone numbers, dates of birth, hashed passwords (the vast majority with bcrypt) and, in some cases, encrypted or unencrypted security questions and answers. More>>


Rural Branches: Westpac To Close 19 Branches, ANZ Looks At 7

Westpac confirms it will close nineteen branches across the country; ANZ closes its Ngaruawahia branch and is consulting on plans to close six more branches; The bank workers union says many of its members are nervous about their futures and asking ... More>>

Interest Rates: RBNZ's Wheeler Keeps OCR At 2%

Reserve Bank governor Graeme Wheeler kept the official cash rate at 2 percent and said more easing will be needed to get inflation back within the target band. More>>


Get More From Scoop

Search Scoop  
Powered by Vodafone
NZ independent news